Maria Balazova

Dr. Maria Balazova

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Biochimica et Biophysica Acta (BBA) - Bioenergetics
Verified
Journal Article
Closed access
LPLucia Pokorná
Lucia Pokorná
PČPetra Čermáková
Petra Čermáková
AHAnton Horváth
Anton Horváth
MBMatthew G. Baile
Matthew G. Baile
SCSteven M. Claypool
Steven M. Claypool
MBMaria Balazova
Maria Balazova

1 September 2017 in European Journal of Cell Biology
Verified
Journal Article
Closed access
KVKatarína Vaškovičová
Katarína Vaškovičová
TAThuraya Awadová
Thuraya Awadová
PVPetra Veselá
Petra Veselá
MBMaria Balazova
Maria Balazova
MOMiroslava Opekarová
Miroslava Opekarová
Jan MalinskyJan Malinsky
Jan Malinsky

19 May 2017 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
MCMaria Chomova
Maria Chomova
MBMaria Balazova
Maria Balazova
JMJana Muchova
Jana Muchova

23 October 2013 in FEMS Yeast Research
Verified
Journal Article
Open access
PDF file
EGEduard Goffa
Eduard Goffa
ZBZuzana Balazfyova
Zuzana Balazfyova
NHNora Toth Hervay
Nora Toth Hervay
ZSZuzana Simova
Zuzana Simova
MBMaria Balazova
Maria Balazova
YGYvetta Gbelska
Yvetta Gbelska
KlPDR16 is a new multidrug resistance determinant in Kluyveromyces lactis

2 December 2021 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PKPaulína Káňovičová
Paulína Káňovičová
PČPetra Čermáková
Petra Čermáková
DKDominika Kubalová
Dominika Kubalová
LBLenka Bábelová
Lenka Bábelová
PVPetra Veselá
Petra Veselá
MBMaria Balazova
Maria Balazova
Barth syndrome (BTHS) is an inherited mitochondrial disorder characterized by a decrease in total cardiolipin and the accumulation of its precursor monolysocardiolipin due to the loss of the transacylase enzyme tafazzin. However, the molecular basis of BTHS pathology is still not well understood. Here we characterize the double mutant pgc1Δtaz1Δ of Saccharomyces cerevisiae deficient in phosphatidylglycerol-specific phospholipase C and tafazzin as a new yeast model of BTHS. Unlike the taz1Δ mutant used to date, this model accumulates phosphatidylglycerol, thus better approximating the human BTHS cells. We demonstrate that increased phosphatidylglycerol in this strain leads to more pronounced mitochondrial respiratory defects and an increased incidence of aberrant mitochondria compared to the single taz1Δ mutant. We also show that the mitochondria of the pgc1Δtaz1Δ mutant exhibit a reduced rate of respiration due to decreased cytochrome c oxidase and ATP synthase activities. Finally, we determined that the mood-stabilizing anticonvulsant valproic acid has a positive effect on both lipid composition and mitochondrial function in these yeast BTHS models. Overall, our results show that the pgc1Δtaz1Δ mutant better mimics the cellular phenotype of BTHS patients than taz1Δ cells, both in terms of lipid composition and the degree of disruption of mitochondrial structure and function. This favors the new model for use in future studies.

23 October 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
KVKatarina Vaskovicova
Katarina Vaskovicova
PVPetra Vesela
Petra Vesela
JZJakub Zahumensky
Jakub Zahumensky
DFDagmar Folkova
Dagmar Folkova
MBMaria Balazova
Maria Balazova
Jan MalinskyJan Malinsky
Jan Malinsky
Membrane proteins are targeted not only to specific membranes in the cell architecture, but also to distinct lateral microdomains within individual membranes to properly execute their biological functions. Yeast tetraspan protein Nce102 has been shown to migrate between such microdomains within the plasma membrane in response to an acute drop in sphingolipid levels. Combining microscopy and biochemistry methods, we show that upon gradual ageing of a yeast culture, when sphingolipid demand increases, Nce102 migrates from the plasma membrane to the vacuole. Instead of being targeted for degradation it localizes to V-ATPase-poor, i.e., ergosterol-enriched, domains of the vacuolar membrane, analogous to its plasma membrane localization. We discovered that, together with its homologue Fhn1, Nce102 modulates vacuolar morphology, dynamics, and physiology. Specifically, the fusing of vacuoles, accompanying a switch of fermenting yeast culture to respiration, is retarded in the strain missing both proteins. Furthermore, the absence of either causes an enlargement of ergosterol-rich vacuolar membrane domains, while the vacuoles themselves become smaller. Our results clearly show decreased stability of the V-ATPase in the absence of either Nce102 or Fhn1, a possible result of the disruption of normal microdomain morphology of the vacuolar membrane. Therefore, the functionality of the vacuole as a whole might be compromised in these cells.